ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993

ACS Seeks Applications For Clinical Awards

January 1, 1993

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992